Scholars@Duke

When to Offer Thromboprophylaxis to Patients With Advanced Pancreatic Cancer: Shedding Light on the Path Forward.

Publication ,  Journal Article
Lyman, GH; Kuderer, NM
Published in: J Clin Oncol
June 20, 2015
Published version (DOI) Link to item

Duke Scholars

Gary Herbert Lyman
Author Gary Herbert Lyman Medicine, Medical Oncology

Published In

J Clin Oncol

DOI

10.1200/JCO.2015.61.4164

EISSN

1527-7755

Publication Date

June 20, 2015

Volume

33

Issue

18

Start / End Page

1995 / 1997

Location

United States

Related Subject Headings

  • Pancreatic Neoplasms
  • Oncology & Carcinogenesis
  • Male
  • Humans
  • Heparin, Low-Molecular-Weight
  • Female
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lyman, G. H., & Kuderer, N. M. (2015). When to Offer Thromboprophylaxis to Patients With Advanced Pancreatic Cancer: Shedding Light on the Path Forward. J Clin Oncol, 33(18), 1995–1997. https://doi.org/10.1200/JCO.2015.61.4164
Lyman, Gary H., and Nicole M. Kuderer. “When to Offer Thromboprophylaxis to Patients With Advanced Pancreatic Cancer: Shedding Light on the Path Forward.” J Clin Oncol 33, no. 18 (June 20, 2015): 1995–97. https://doi.org/10.1200/JCO.2015.61.4164.
Lyman, Gary H., and Nicole M. Kuderer. “When to Offer Thromboprophylaxis to Patients With Advanced Pancreatic Cancer: Shedding Light on the Path Forward.” J Clin Oncol, vol. 33, no. 18, June 2015, pp. 1995–97. Pubmed, doi:10.1200/JCO.2015.61.4164.

Published In

J Clin Oncol

DOI

10.1200/JCO.2015.61.4164

EISSN

1527-7755

Publication Date

June 20, 2015

Volume

33

Issue

18

Start / End Page

1995 / 1997

Location

United States

Related Subject Headings

  • Pancreatic Neoplasms
  • Oncology & Carcinogenesis
  • Male
  • Humans
  • Heparin, Low-Molecular-Weight
  • Female
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences